Economic Incentives and vDOT for Latent Tuberculosis Infection

NARecruitingINTERVENTIONAL
Enrollment

399

Participants

Timeline

Start Date

February 7, 2022

Primary Completion Date

February 1, 2027

Study Completion Date

December 1, 2027

Conditions
Latent Tuberculosis
Interventions
BEHAVIORAL

Usual Care

Medication is dispensed to participant at each visit in 30-60 day supplies by Baltimore City Health Department (BCHD) nurses. For study participants, medication dispensation will occur in medication bottles with MEMS Caps, supplied by the study.

BEHAVIORAL

Video Directly Observed Therapy alone

Usual care plus Video-DOT using the emocha platform, a HIPAA compliant commercial platform for video based DOT. The app allows a secure/encrypted video recording to be taken as the participant ingests the medication. Electronic text reminders will be sent to the participant on the smart phone when it is time to take the medication. The participant will record a video of the pill ingestion process. Study staff will verify each video to confirm the video shows the correct person and that the pill was ingested appropriately (according to standardized approach involving visualization of the pills, ingestion and observation of an empty mouth after ingestion).

BEHAVIORAL

Video Directly Observed Therapy plus Financial Incentives

Usual care plus video-DOT and financial incentives contingent on adherence verified by video DOT. The amount of the financial incentive that can be earned for future verified doses decreases after a missed dose (video). The amount of the financial incentives increases incrementally back to baseline amount after verification of medication ingestion according to the prescribed schedule for several consecutive doses.

Trial Locations (1)

21205

RECRUITING

Baltimore City Health Department, and Baltimore metropolitan area clinics and health departments, Baltimore

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Johns Hopkins University

OTHER